Advanced search×


Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Proquest, Rcgp, CSA, Ingenta, Wiley from 1948, Gale, and Ovid from 2005

  1. Issue information.
    Author(s) unavailable

    Cancer 120 Suppl 16:i (2014) PMID 25099908

  2. Patterns of recurrence after trimodality therapy for esophageal cancer.

    Cancer 120(14):2099 (2014) PMID 24711267

    Patterns of failure after neoadjuvant chemoradiotherapy and surgery for esophageal cancer are poorly defined. All patients in the current study were treated with trimodality therapy for nonmetastatic esophageal cancer from 1995 to 2009. Locoregional failure included lymph node failure (NF), anastomo...
  3. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

    Cancer 120(14):2150 (2014) PMID 24723129

    α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in these patients have not been adequately explored. For this study, the authors evaluated the relevance of demographic, clinical...
  4. Consensus statement released for treating melanoma patients with immunotherapy.

    Cancer 120(1):3 (2014) PMID 24347380

  5. Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.

    Cancer 119(5):1004 (2013) PMID 23132729

    The promoter of Id4 was methylated in 23 of 62 (37%) GBMs. In methylated GBMs, Id4 mRNA was significantly reduced, compared with unmethylated GBMs (P = .0002). A significant reduction of protein expression was detected in all hypermethylated cases. GBMs with methylated Id4 showed a significant reduc...
  6. Dramatic rise in skin cancer seen in young adults.

    Cancer 118(16):3881 (2012) PMID 22864931

  7. Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Canc...

    Cancer 118(5):1422 (2012) PMID 21823111

    For patients with lung, pancreatic, and head and neck tumors who were treated on phase 1 trials, survival was predicted accurately by the RMH prognostic score. Cancer 2011;. © 2011 American Cancer Society. Copyright © 2011 American Cancer Society....
  8. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patient...

    Cancer 118(5):1457 (2012) PMID 21837676

    The final QLQ-BM22 module contains 22 items and 4 scales assessing Painful Sites, Painful Characteristics, Functional Interference, and Psychosocial Aspects. Results confirmed the validity, reliability, cross-cultural applicability, and sensitivity of the 22-item EORTC QLQ-BM22. It is therefore reco...
  9. Clinical outcomes of oncologic gastrointestinal resections in patients with cirrhosis.

    Cancer 118(14):3494 (2012) PMID 22170573

    Resection of GI malignancy in cirrhotics is associated with poor early postoperative and transitional outcomes, with severity of liver disease being the primary determinant of postoperative mortality. These data suggest that GI cancer operations can be performed safely in well-selected cirrhotic pat...
  10. Researchers report discoveries in cancer progression and rare skin and pancreatic cancers.

    Cancer 117(24):5435 (2011) PMID 22139631